Safety and Efficacy of EchoNavigator System Release II During Structural Heart Interventions — EchoNav  

Cardiac Imaging Techniques Clinical Trial

Official title: Safety and Efficacy of EchoNavigator System Release II (Philips, Andover, MA) During Structural Heart Interventions

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is to collect data regarding the safety and efficacy of EchoNavigator System Release II during structural heart interventions in the clinical practice. Data of procedures with and without the use of EchoNavigator System Release II will be collected, analysed and evaluated.

Clinical Trial Description

EchoNavigator System Release II is a CE certified innovative periinterventional imaging modality used in our clinic of cardiology, pulmonology and angiology during structural heart interventions like transfemoral aortic valve Implantation (TAVI), MitraClip implantation, patent foramen ovale (PFO), atrial septal defect (ASD) and left atrial appendage (LAA). During this interventions EchoNavigator is able to combine live X-ray Images and 3D Echo guidance to enhance the efficiency of the procedure. Specific periprocedural data parameter, e.g. procedure duration, radiation time, radiation dose, transseptal punction time (e.g.LAA) and contrast agent amount will be collected and analysed. The same data characteristics from the same procedures but without the periinterventional use of the EchoNavigator System Release II will be collected, analysed and compared with the data described above. A retrospective data collection between 2013 - 2017 of n=500 patients will be conducted. ;

Related Conditions & MeSH terms

• Cardiac Imaging Techniques

• NCT number: NCT02608008
• Study type: Observational
• Source: Heinrich-Heine University, Duesseldorf
• Status: Active, not recruiting
• Start date: September 2014
• Completion date: June 2021